Vertical SaaS Valuation Multiples: Healthcare, Fintech, Legal, Construction
Vertical SaaS (software for specific industries) commands different multiples than horizontal. Regulatory moats and workflow lock-in drive premiums in healthcare and fintech.
Vertical vs Horizontal SaaS: Why It Matters for Valuation
Vertical SaaS is software built for a specific industry (healthcare, legal, construction) rather than a general business function (email, CRM, analytics). The valuation implications are significant:
Healthcare (HIPAA), fintech (PCI, banking regulations), and legal (bar compliance) create compliance barriers that make switching extremely difficult and expensive.
When your SaaS is embedded in how a hospital bills patients or how a law firm tracks time, leaving requires re-training, data migration, and regulatory re-certification.
Vertical SaaS typically achieves NRR 5-10 points higher than horizontal SaaS peers because of lower churn. A healthcare practice management system sees 2-3% annual churn vs 10-15% for horizontal CRM.
Multiples by Vertical (2026)
| Vertical | Typical EV/ARR | Premium Drivers | Notable Companies |
|---|---|---|---|
| Healthcare/MedTech | 5-12x | Regulatory moat (HIPAA), compliance lock-in | Veeva, Phreesia, Epic |
| Fintech/Payments | 6-14x | Network effects, PCI compliance, data value | nCino, Blend, FIS vertical |
| Legal Tech | 4-8x | Workflow integration, billing critical path | Clio, MyCase, Relativity |
| HR/Payroll/Workforce | 3-6x | Payroll compliance, float, system-of-record lock-in | Workday, Paycom, Paylocity, Paychex, ADP |
| Construction/Field Service | 3-7x | Project management dependency | Procore, Buildertrend, ServiceTitan |
| Restaurant/Retail | 3-6x | POS dependency, but high SMB churn risk | Toast, Lightspeed, TouchBistro |
| Real Estate | 3-6x | Market cyclicality creates churn risk | CoStar, Buildout, Yardi |
Segment Deep Dives
Healthcare/MedTech: 5-12x ARR
Healthcare SaaS commands premium multiples because HIPAA compliance, EHR integrations, and billing workflows create near-impenetrable switching barriers. Veeva Systems (pharmaceutical CRM) has traded at 20-30x EV/Revenue at peaks, demonstrating the premium for best-in-class regulatory moats. Healthcare IT buyers are typically large health systems and insurers with long procurement cycles, which means high implementation costs and extremely low churn. NRR for healthcare SaaS typically runs 110-120%.
Read the full healthtech SaaS multiples analysis →Fintech/Payments: 6-14x ARR
Fintech SaaS benefits from network effects (more users = more valuable data), regulatory barriers (banking licenses, PCI compliance), and high switching costs once integrated into a bank's core infrastructure. nCino (bank operating system) IPO'd at approximately 30x EV/Revenue in 2020. Blend (mortgage platform) is another example. The range is wide because payments companies with network effects can achieve 12-14x, while simpler fintech workflow tools are closer to 6-8x.
Read the full fintech SaaS multiples analysis →AI-Native SaaS: a widening split
AI is the defining valuation variable of 2026, and it cuts both ways. AI-native infrastructure and copilots with defensible data positions are re-rated upward, while horizontal SaaS whose core workflow an AI agent can replace (basic support, generic analytics, simple CRM) is being marked down regardless of historic growth. The dispersion inside the "AI SaaS" label is now wider than the gap between most traditional verticals.
Read the full AI SaaS multiples analysis →DevOps & Observability: 8-15x ARR
Developer-tooling and observability platforms sit at the premium end of the vertical map. Consumption-based pricing that scales with a customer's own usage, deep CI/CD and runtime integration, and mission-critical incident workflows produce high NRR and structurally low churn. The category spans security devtools and monitoring leaders that anchor the top of the 8-15x band.
Read the full DevOps SaaS multiples analysis →Legal Tech: 4-8x ARR
Legal SaaS (Clio, MyCase, Relativity) benefits from being embedded in billing and time-tracking workflows that lawyers rely on daily. Switching is painful and disruptive. The limitation is that law firms are conservative buyers with long sales cycles and the market is relatively concentrated. Top-quartile legal SaaS companies with strong expansion into enterprise law firms can achieve 8-10x, while SMB legal SaaS firms are typically 4-6x.
HR & Payroll: 3-6x ARR
HR and payroll SaaS splits into two valuation regimes in 2026. Modern cloud HCM pure-plays re-rated down toward the broad software median (Workday ~3.0x, Paycom ~3.1x, Paylocity ~3.3x EV/Revenue), while mature payroll-services incumbents earn a profit premium on float, ~35-40% margins, and decades-long retention (Paychex ~6.0x, ADP ~4.2x). Private buyers paid the system-of-record premium: Thoma Bravo took Dayforce private at roughly 6.2x ($12.3B), and Paychex bought Paycor for $4.1B.
Read the full HR & payroll SaaS multiples analysis →Construction/Field Service: 3-7x ARR
Construction SaaS (Procore, Buildertrend) has strong workflow lock-in for active projects, but construction is inherently cyclical. During market downturns, construction activity falls and SaaS churn can spike as builders cut costs. This cyclical risk caps multiples below healthcare and fintech. ServiceTitan (field service) represents the premium end at 6-8x due to its broader field service TAM and strong NRR. Project management tools at the small end are closer to 3-4x.
Read the full construction tech SaaS multiples analysis →Real Estate & PropTech: 3-6x ARR
Real estate and proptech SaaS (AppFolio, CoStar, Yardi) is rate-sensitive and cyclical, which caps the band below healthcare and fintech. Property-management software is the defensive core because buildings need running in any market: AppFolio trades at roughly 5.4x revenue. CoStar runs lower at roughly 3.6x because its mix leans on data and the Homes.com marketplace rather than pure subscription. Transaction- and origination-led tools price lower still.
Read the full real estate & proptech SaaS multiples analysis →